Pharma Two B
Rehovot
About Pharma Two B
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $38.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2017)
- Website: pharma2b.com
- Phone: 972 8 947 2672
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharma-two-b-84228 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.